ABALLI JOHN (President and CEO) sold 7.5% of their position (33.82K shares) of EXAGEN INC. on the open market
Open‑market sale worth $59.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/18/2023ACC: 0001274737-23-000094
DirectorOfficer· President and CEO
Since Mar 2026
-33.82K
Net shares
Net seller
$59.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
33.82K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−33.82K
Price / share
$1.75
Trade value
$59.02K
% of position
7.5%
10/17/2023
449.80K→415.98K
Total
Net shares
−33.82K
Net value
-$59.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/17/2023 | S · Sale | −33.82K | $1.75 | $59.02K | 7.5% | 449.80K | 415.98K |
| Total | −33.82K | -$59.02K | ||||||
Derivative Transactions0
No derivative transactions reported